- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
51 Cards in this Set
- Front
- Back
|
5HT is synthesized from?
|
Tryptophan (in diet; in 2 steps)
|
|
Describe platelets' relationship to 5HT.
|
They don't synthesize it, but take it up from blood (active uptake process in platelets and nerve terminals)
|
|
Highest % of 5HT is where in body?
|
90% in GI enterochromaffin cells; rest is in platelets and brain
|
|
Rate limiting enz for 5HT synth?
|
tryptophan hydroxylase
|
|
MAO inhibitors and interaction with 5HT?
|
Inhibit breakdown/metabolism of 5HT to 5-OH Indole Acetaldehyde (promote serotonin syndrome)
|
|
What inhibits 5HT uptake into CNS?
|
other amino acids
|
|
Inhibits 5HT synthesis?
|
p-chlorophenylalanine (irreversible)
|
|
Inhibit 5HT neuronal re-uptake?
|
cocaine, SSRA (fluoxetine), TCA (imipramine)
|
|
Inhibit 5HT storage, lead to 5HT depletion?
|
reserpine
|
|
Inhibit 5HT metabolism?
|
MAO inhibitors
|
|
Promote 5HT release?
|
p-chloroamphetamine, which then depletes overall 5HT levels
|
|
How many 5HT receptor subtypes?
|
at least 15, with multiple transduction mechanisms
|
|
5HT1-A?
|
role in anxiety/depression
|
|
5HT1-D?
|
role in migraine
|
|
5HT-2?
|
role in CNS behaviors; places more emphasis on cardiovascular role
|
|
5HT-3?
|
role in nausea and vomiting (esp due to chemo)
|
|
Endogenous fxns of 5HT?
|
Central NT
Melatonin precursor Inc GI motility* carcinoid tumor (inc 5HT): diarrhea, bronchoconstriction, edema Platelets: 5HT-2 receptors-->aggregation, vasoconstriction |
|
Pharmacological fxns of 5HT?
|
Respiratory: bronchoconstriction (contraindicated in asthma); stim aortic, carotid chemoreceptors and inc RR
GI: intense rhythmic contractions due to direct and indirect effects (sm intestine very 5HT sensitive) Vagal: 5HT-3 receptors on afferents --> stim vomiting |
|
Cardio effects of 5HT?
|
1. direct (immediate) large artery vasoconstriction, indirect (NO and PGI2, prolonged) vasodilation
2. Heart: direct ionotrope, chronotrope 3. Reflex mech due to change in BP 4. Stim sensory nerve endings in baroreceptors, vagal afferents --> bradycardia, hypotension (with overdose) |
|
CNS effects of 5HT?
|
1. pain perception
2. sleep/wakefulness 3. behaviors (depression, schizophrenia, OCD etc) 4. neuroendocrine regulation (control hypothalamic cells involved in ant pituitary hormones) |
|
Examples of 5HT agonists?
|
sumatriptan
fluoxetine buspirone cisapride LSD ergot alkaloids |
|
MOA--sumatriptan
|
5HT1-D agonist; contraindicated in angina; used for migraine
|
|
MOA--fluoxetine
|
SSR; depression
|
|
MOA--buspirone
|
5HT1-A agonist; for anxiety
|
|
MOA--cisapride
|
5HT4 agonist; inc GI motility, dec G-E reflux (taken off market for fatal arrhythmias*)
|
|
MOA--LSD
|
5HT1-A; hallucinogen
|
|
MOA--ergot alkaloids
|
5HT1, 2 agonist
|
|
List 5HT antagonists
|
methylsergide, cyproheptadine
ketanserin ondansetron clozapine |
|
MOA--methylsergide, cyproheptadine
|
5HT2 antagonists; used for carcinoid, migraines
|
|
MOA--ketanserin
|
5HT2, alpha antagonist; antihypertensive
|
|
MOA--ondansetron
|
5HT3 antagonist; for chemotherapy induced n/v
|
|
MOA--clozapine
|
5HT2A/2C antagonist; for schizophrenia
|
|
Sx's of common allergic rxns?
|
Bronchoconstriction***
(rhinitis, conjunctivitis, urticaria, dermatitis, anaphylaxis) |
|
Release of histamine?
|
synth by decarboxylation of histidine; released from mast cells when stim by IgE due to foregin Ag in body
|
|
H1 receptor: location, fxn
|
sm muscle, endothelium, CNS;
vasodilation, bronchoconstriction, sm muscle activation, separation of endothelial cells |
|
H2 receptor: location, fxn
|
parietal cells;
regulate gastric acid secretion |
|
H3 receptor: location, fxn
|
CNS;
regulate release of other NTs |
|
H4 receptor?
|
recently discovered, widespread (organs of digestive tract, basophils, bone marrow), unknown fxn
|
|
Describe (generally) 1st generation antihistamines
|
small, lipophilic (cross BBB), not specific to H1; highest sedation among antihistamines
|
|
Describe (generally) 2nd generation antihistamines
|
more specific to peripheral H1 receptor; less sedation than 1st gen (but when given in higher dose, will still cause sedation)
|
|
Describe (generally) 3rd generation antihistamines
|
metabolite derivatives or active enantiomers of prior antihistamines; safer, faster, more potent than 2nd gen (will still give sedation if given in higher dose, but less sedation than 2nd or 1st)
|
|
Pharmacokinetics of 2nd generation antihistamines?
|
rapid onset, half lives= loratidine 24 hrs, fexofenedine 14 hrs, cetirizine 8 hours (kids metabolize cetirizine faster; rates similar for others)
|
|
Eicosanoids overview?
|
Be aware that multiple classes (PGs, TXA, PGI, LT) that do opposite things (vasoconstriction vs vasodilation)
|
|
Dinoprostone
|
generic name for PGE-2, relax uterine sm muscle when labor is induced; to terminate pregnancy in early stages
|
|
Misoprostol
|
analogue of PGE-1, prevent gastric ulcers
|
|
Mediators of pulmonary HTN?
|
serotonin (5HT), endothelin-1 (ET)
|
|
Endothelin-1
|
potent vasoconstrictor; plasma levels are increased in pulm HTN
|
|
Bosentan
|
sulphonamide based ET-A & ET-B receptor blocker; contraindicated in pregnancy for teratogenic effects**; induces CYP2C9, CYP3A4
|
|
Sitaxentan
|
sulphonamide based selective ET-A antagonist (ET-A:ET-B 6500:1); CYP2C9 metabolism-->interacts with warfarin
|
|
MC adverse fx's with sitaxentan?
|
headache, constipation, dizziness, insomnia
|
|
Ambrisentan
|
non-sulphonamide ET-A moderately selective (260:1) antagonist; no interaxn w coumarin based anticoagulants
|